Dose-ranging study of the luteinizing hormone-releasing hormone receptor antagonist cetrorelix pamoate in the treatment of patients with symptomatic benign prostatic hyperplasia.
Debruyne
Frans
F
Department of Urology, Academic Hospital Nijmegen, Nijmegen, The Netherlands. f.debruyne@uroweb.org
Tzvetkov
Mitko
M
Altarac
Silvio
S
Geavlete
Petrisor A
PA